SCHEMBL19279196

SCHEMBL19279196

N#Cc1ccc(N[C@H]2CCN(C(=O)O)C2)c2c3c([nH]c12)CCCC3

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 16/20 0.59
▸ JAK3 P52333 2/20 0.41
▸ USP30 Q70CQ3 1/20 0.35
▸ CTSK P43235 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19279198 1.00 BTK (0.59) BTKJAK3USP30CTSK
SCHEMBL28380741 0.86 BTK (0.53) BTK
SCHEMBL19715377 0.86 BTK (0.53) BTK
SCHEMBL19715385 0.85 BTK (0.65) BTKJAK3
SCHEMBL19715384 0.85 BTK (0.65) BTKJAK3
SCHEMBL21509054 0.82 BTK (0.49) BTKJAK3
SCHEMBL28498049 0.82 BTK (0.58) BTKJAK3
SCHEMBL17699972 0.82 BTK (0.58) BTKJAK3
SCHEMBL19715376 0.77 BTK (0.41) BTKCTSK
SCHEMBL19715346 0.76 BTK (0.40) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053197-B2 Carbazole derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2021-07-06 — — US disclosed
US-20200255377-A1 CARBAZOLE DERIVATIVES Organization Name: BRISTOL-MYERS SQUIBB COMPANY (US) 2020-08-13 — — US disclosed
US-10676434-B2 Carbazole derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2020-06-09 — — US disclosed
EP-3209651-B9 CARBAZOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2020-05-20 — — EP disclosed
CN-107074804-B Carbazole derivatives 百时美施贵宝公司 2020-02-18 — — CN disclosed
EP-3209651-B1 CARBAZOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2019-10-23 — — EP disclosed
US-20190225583-A1 CARBAZOLE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2019-07-25 — — US disclosed
US-10266491-B2 Carbazole derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-23 — — US disclosed
US-20170362176-A1 CARBAZOLE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2017-12-21 — — US disclosed
EP-3209651-A1 CARBAZOLE DERIVATIVES Bristol-Myers Squibb Company (US) 2017-08-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266491-B2 Carbazole derivatives BTK, SYK, JAK2 BTK 1/4885JAK3 6/4885USP30 1863/4885
US-10676434-B2 Carbazole derivatives BTK, SYK, JAK2 BTK 1/4885JAK3 6/4885USP30 1816/4885
US-20170362176-A1 CARBAZOLE DERIVATIVES BTK, SYK, JAK2 BTK 1/4885JAK3 6/4885USP30 1863/4885
US-11053197-B2 Carbazole derivatives BTK, SYK, JAK2 BTK 1/4885JAK3 6/4885USP30 1816/4885
US-20190225583-A1 CARBAZOLE DERIVATIVES BTK, SYK, JAK2 BTK 1/4885JAK3 6/4885USP30 1816/4885
US-20200255377-A1 CARBAZOLE DERIVATIVES BTK, SYK, JAK2 BTK 1/4885JAK3 6/4885USP30 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback